Keith D. Dawkins, MD, FRCP, FACC

Original Contribution

Serial Intravascular Ultrasound Analysis of Stent Strut Distribution and Fracture: An Integrated Analysis of the Taxus IV, V, and VI Trials

09/27/2014

Stephen G. Ellis , MD;

Jeffrey J. Popma , MD, FACC, FSCAI;

Radoslaw Pracon , MD;

Jerzy Pregowski , MD, PhD;

Maksymilian P. Opolski , PhD, MD;

Mariusz Kruk , MD;

Lazar Mandinov , MD;

Hong Wang ;

Gregg W. Stone , MD, FACC, FSCAI;

Gary S. Mintz , MD;

Neil J. Weissman , MD;

Keith D. Dawkins , MD, FRCP, FACC;

Eberhard Grube , MD;

Non-uniform distribution of drug-eluting stent struts may cause uneven drug deposition associated with an adverse neointimal response and clinical events. This study assesses circumferential stent strut distribution in bare-metal (BMS, n=117)...

Non-uniform distribution of...

09/27/2014

Journal of Invasive Cardiology

Troponin-Positive Chest Pain with Unobstructed Coronary Arteries: A Role for Delayed Enhanced Cardiovascular Magnetic Resonance

08/01/2008

Nick G. Bellenger , MD, BSc, MRCP;

Stephen Harden , RCS, FRCR;

Charles F. Peebles , DPM, MRCP, FRCR;

Keith D. Dawkins , MD, FRCP, FACC;

Nick Curzen , PhD, FRCP, FESC;

Acute coronary syndromes represent a significant health burden and convey a prognosis that is far from benign. Indeed, United Kingdom registry data reveal that 6 months following admission for a non-ST elevation myocardial infarction...

Acute coronary syndromes...

08/01/2008

Journal of Invasive Cardiology

Drug-Eluting Stent Solutions

06/19/2008

Keith D. Dawkins , MD, FRCP, FACC;

How does the TAXUS VI clinical trial fit into the TAXUS Stent clinical trial series?> The TAXUS VI clinical trial is the most recent of six clinical trials over four years to study the safety and efficacy of Boston Scientific's TAXUS...

How does the TAXUS VI clinical...

06/19/2008

Cath Lab Digest

Feature

Drug-Eluting Stent Solutions

06/19/2008

Keith D. Dawkins , MD, FRCP, FACC;

How does the TAXUS VI clinical...

06/19/2008

Cath Lab Digest

IAGS (International Andreas Gruentzig Society) Proceedings

Malignancy: An Unrecognized Risk Factor for Coronary Stent Thrombosis?

08/01/2008

Alex R. Hobson , BSc, MRCP;

Vijayalakshmi Kunadian , MBBS, MD, MRCP;

Blan Purcell , BSc, MD, MRCP;

Azfar G. Zaman , BSc, MD, FRCP, MBChB;

Daniel B. McKenzie , MRCP, BMedSci;

Keith D. Dawkins , MD, FRCP, FACC;

Nick Curzen , PhD, FRCP, FESC;

_______________________________________________ J INVASIVE CARDIOL 2008;20:E120-E123 Stent thrombosis (ST) is an important, life-threatening complication of percutaneous coronary intervention (PCI) and coronary stent placement that has...

...

08/01/2008

Journal of Invasive Cardiology